GAIL GILTNER: Open Payments
NPI 1558413856 · GRANTS PASS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 15 payments from 9 companies in 2025. Trend: 2023 $262 · 2024 $320 · 2025 $327
Food & beverage: $311Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Novo Nordisk Inc | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| PFIZER INC. | 1 | $21 |
| Amgen Inc. | 1 | $13 |
Products named: REXULTI, TRELEGY ELLIPTA, AIRSUPRA, BREZTRI, Wegovy, ZENPEP, The Cologuard Plus Collection Kit, VRAYLAR.
Industry payments across OR — which companies pay providers there.
